Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: Patients' and professionals' perspectives

Gynecologic Oncology

Volumn 136, Issue 2, 2015, Pages 305-310

  Arts De Jong, Marieke ^a   Harmsen, Marline G ^a   Hoogerbrugge, Nicoline ^a   Massuger, Leon F ^a   Hermens, Rosella P ^a   De Hullu, Joanne A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA mutation; Ovarian cancer; Patients' perspectives; Professionals' perspectives; Risk reducing strategy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGING; ARTHROPATHY; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER FAMILY; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONCEPTUAL FRAMEWORK; DISEASE SEVERITY; EARLY MENOPAUSE; FEMALE; FOLLOW UP; GENE MUTATION; HEALTH PERSONNEL ATTITUDE; HUMAN; LIFE EXPECTANCY; MALE; MEDICAL DECISION MAKING; MOOD CHANGE; OSTEOPOROSIS; OVARIECTOMY; OVARY CARCINOMA; OVARY FUNCTION; PATIENT COUNSELING; PATIENT DECISION MAKING; PATIENT INFORMATION; PERSONAL APPEARANCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCING OOPHORECTOMY; RISK REDUCING SALPINGECTOMY; RISK REDUCING SALPINGOOOPHORECTOMY; RISK REDUCTION; SALPINGECTOMY; SEMI STRUCTURED INTERVIEW; SEXUAL DYSFUNCTION; SLEEP DEPRIVATION; THERAPY EFFECT; TREATMENT OUTCOME; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PROCEDURES; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; OVARIECTOMY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SALPINGECTOMY;

EID: 84923106388     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.12.031     Document Type: Article

References (34)

1. K. Alsop, S. Fereday, C. Meldrum, A. deFazio, C. Emmanuel, J. George, et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation - positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group J Clin Oncol 30 21 2012 2654 2663 [Epub 2012/06/20]
2. S. Zhang, R. Royer, S. Li, J.R. McLaughlin, B. Rosen, H.A. Risch, et al. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer Gynecol Oncol 121 2 2011 353 357 [Epub 2011/02/18]
3. H.A. Risch, J.R. McLaughlin, D.E. Cole, B. Rosen, L. Bradley, E. Kwan, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 68 3 2001 700 710 [Epub 2001/02/17]
4. S. Chen, and G. Parmigiani Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 11 2007 1329 1333 [Epub 2007/04/10]
5. R.M. Brohet, M.E. Velthuizen, F.B. Hogervorst, H. Ej Meijers-Heijboer, C. Seynaeve, M.J. Collee, et al. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations J Med Genet 51 2 2014 98 107 [Epub 2013/11/29]
6. T.R. Rebbeck, N.D. Kauff, and S.M. Domchek Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 2 2009 80 87 [Epub 2009/01/15]
7. A. Eisen, J. Lubinski, J. Klijn, P. Moller, H.T. Lynch, K. Offit, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study J Clin Oncol 23 30 2005 7491 7496 [Epub 2005/10/20]
8. N. Mavaddat, S. Peock, D. Frost, S. Ellis, R. Platte, E. Fineberg, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE J Natl Cancer Inst 105 11 2013 812 822 [Epub 2013/05/01]
9. I.E. Fakkert, M.J. Mourits, L. Jansen, D.M. van der Kolk, K. Meijer, J.C. Oosterwijk, et al. Breast cancer incidence after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers Cancer Prev Res 5 11 2012 1291 1297 [Epub 2012/09/27]
10. A. Finch, K.A. Metcalfe, J.K. Chiang, L. Elit, J. McLaughlin, C. Springate, et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation Gynecol Oncol 121 1 2011 163 168 [Epub 2011/01/11]
11. J.B. Madalinska, M. van Beurden, E.M. Bleiker, H.B. Valdimarsdottir, J. Hollenstein, L.F. Massuger, et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy J Clin Oncol 24 22 2006 3576 3582 [Epub 2006/08/01]
12. F. Atsma, M.L. Bartelink, D.E. Grobbee, and Y.T. van der Schouw Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis Menopause (NY) 13 2 2006 265 279 [Epub 2006/04/29]
13. O. Svejme, H.G. Ahlborg, J.A. Nilsson, and M.K. Karlsson Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women BJOG 119 7 2012 810 816 [Epub 2012/04/26]
14. W.A. Rocca, B.R. Grossardt, and D.M. Maraganore The long-term effects of oophorectomy on cognitive and motor aging are age dependent Neurodegener Dis 5 3-4 2008 257 260 [Epub 2008/03/07]
15. K.L. Bolton, G. Chenevix-Trench, C. Goh, S. Sadetzki, S.J. Ramus, B.Y. Karlan, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer JAMA 307 4 2012 382 390 [Epub 2012/01/26]
16. R.J. Kurman, and Ie M. Shih The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory Am J Surg Pathol 34 3 2010 433 443 [Epub 2010/02/16]
17. C.P. Crum, R. Drapkin, A. Miron, T.A. Ince, M. Muto, D.W. Kindelberger, et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis Curr Opin Obstet Gynecol 19 1 2007 3 9 [Epub 2007/01/16]
18. M.H. Roh, D. Kindelberger, and C.P. Crum Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am J Surg Pathol 33 3 2009 376 383 [Epub 2008/11/18]
19. D.W. Kindelberger, Y. Lee, A. Miron, M.S. Hirsch, C. Feltmate, F. Medeiros, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship Am J Surg Pathol 31 2 2007 161 169 [Epub 2007/01/27]
20. M.H. Roh, Y. Yassin, A. Miron, K.K. Mehra, M. Mehrad, N.M. Monte, et al. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression Mod Pathol Off J U S Can Acad Pathol Inc. 23 10 2010 1316 1324 [Epub 2010/06/22]
21. A.K. Folkins, E.A. Jarboe, A. Saleemuddin, Y. Lee, M.J. Callahan, R. Drapkin, et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations Gynecol Oncol 109 2 2008 168 173 [Epub 2008/03/18]
22. M.J. Mingels, T. Roelofsen, J.A. van der Laak, J.A. de Hullu, M.A. van Ham, L.F. Massuger, et al. Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls Gynecol Oncol 127 1 2012 88 93 [Epub 2012/06/20]
23. L. Dubeau, and R. Drapkin Coming into focus: the nonovarian origins of ovarian cancer Ann Oncol 24 Suppl. 8 2013 viii28 viii35 [Epub 2013/10/30]
24. J.S. Kwon, A. Tinker, G. Pansegrau, J. McAlpine, M. Housty, M. McCullum, et al. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers Obstet Gynecol 121 1 2013 14 24 [Epub 2012/12/13]
25. C.K. Anderson, S. Wallace, M. Guiahi, J. Sheeder, K. Behbakht, and M.A. Spillman Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer Int J Gynecol Cancer 23 3 2013 417 421 [Epub 2013/02/07]
26. E. Leblanc, F. Narducci, I. Farre, J.P. Peyrat, S. Taieb, C. Adenis, et al. Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development Gynecol Oncol 121 3 2011 472 476 [Epub 2011/03/18]
27. L.L. Holman, S. Friedman, M.S. Daniels, C.C. Sun, and K.H. Lu Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers Gynecol Oncol 133 2 2014 283 286 [Epub 2014/03/04]
28. Mortelmans D. Handboek kwalitatieve onderzoeksmethoden. 1e drIn: Leuven, Voorburg, Acco, editors. 2007 [534 p. p.].
29. M. Fleuren, K. Wiefferink, and T. Paulussen Determinants of innovation within health care organizations: literature review and Delphi study Int J Qual Health Care J Int Soc Qual Health Care/ISQua 16 2 2004 107 123 [Epub 2004/03/31]
30. Grol R, Wensing M, EcclesM. Improving patient care: the implementation of change in clinical practice. New York: Edinburgh, Elsevier Butterworth Heinemann; 2005.
31. M.S. Beattie, B. Crawford, F. Lin, E. Vittinghoff, and J. Ziegler Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers Genet Test Mol Biomarkers 13 1 2009 51 56 [Epub 2009/03/25]
32. R. Manchanda, M. Burnell, A. Abdelraheim, M. Johnson, A. Sharma, E. Benjamin, et al. Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis BJOG 119 5 2012 527 536 [Epub 2012/01/21]
33. L. Sidon, S. Ingham, T. Clancy, R. Clayton, A. Clarke, E.A. Jones, et al. Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women Br J Cancer 106 4 2012 775 779 [Epub 2011/12/22]
34. M. Morelli, R. Venturella, R. Mocciaro, A. Di Cello, E. Rania, D. Lico, et al. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere Gynecol Oncol 129 3 2013 448 451 [Epub 2013/04/06]